Dr Bill Nelson talks with three-time cancer survivor Kristina Baum about the challenges of confronting her disease and successfully running the New York City Marathon… Read More »Cancer Matters with Dr. Bill Nelson – Kristina Baum
Some days, when 37-year-old Kristina Baum laces up her running shoes and starts out on her daily training run, she says she feels like someone… Read More »Three-Time Cancer Survivor Ready for New York Marathon
Researchers at the Johns Hopkins Kimmel Cancer Center say they have added to evidence that measuring and monitoring tumor DNA that naturally circulates in the… Read More »Researchers Advance Role of Circulating Tumor DNA to Detect Early Melanoma Growth, Uncover Treatment Options
This blog post was written by Kristina Baum, who has melanoma and is participating in a clinical trial on immunotherapy at the Johns Hopkins Kimmel… Read More »A perspective on an immunotherapy clinical trial
At the 2016 American Association for Cancer Research annual meeting today, scientists presented their results of a follow-up study tracking the survival of metastatic melanoma… Read More »One-third of patients with metastatic melanoma treated with immunotherapy drug nivolumab survive five years
In today’s news, former President Jimmy Carter, who has metastatic melanoma, revealed that he has responded well to treatment. We asked melanoma expert Evan J.… Read More »Jimmy Carter Announces Cancer Scan Findings
This week, the FDA approved a new therapy called talimogene laherparepvec, which goes by the trade name, Imlygic, for the treatment of certain types of melanoma.… Read More »Melanoma drug FDA approved
Cancer headlines this past month included two studies on colonoscopy, a screening tool for colon cancer. The first study looks at the long-term benefits of… Read More »Cancer News Review
Researchers from the Vanderbilt-Ingram Cancer Center and other institutions reported more data today on studies of a new melanoma drug that target products of a… Read More »More Good News on Melanoma Drug
